Describe the dilemma of health care costs related to advancements in biotechnology and public access to treatments.
Standard detail
A2.5
Performance Indicator
Depth 3Parent ID: 9173E8166F7943B48EAEA34439E0F966Standard set: Health Science and Medical Technology
Original statement
Quick facts
- Statement code
- A2.5
- List ID
- A2.5
- Standard ID
- 3C4540EF3E0E45618645C2F0CD57E3BF
- ASN identifier
- S2541961
- Subject
- CTE (2013-)
- Grades
- 08, 09, 10, 11, 12
- Ancestor IDs
- 9173E8166F7943B48EAEA34439E0F966E581CA64A07147DCB083CF3A22347729E67B4B9EF0B04D75B6C87B3FF4BA2009
- Source document
- CTE Model Curriculum Standards: Health Science and Medical Technology (2013)
- License
- CC BY 3.0 US